<DOC>
	<DOCNO>NCT00861978</DOCNO>
	<brief_summary>The aim ti study assess efficacy safety JarsinÂ® 300 mg acute treatment mild moderate depression atypical feature .</brief_summary>
	<brief_title>St. John 's Wort Extract LI 160 Treatment Atypical Depression</brief_title>
	<detailed_description>The general picture depression still traditionally call endogenous type , also form characterize extensively clinical trial . Atypical depression reverse vegetative sign , hyperphagia hypersomnia , traditionalla neglect , demonstrate fact widely use depression scale , Hamilton Depression Scale , melancholic symptom specific weight , , contrast , reverse vegetative sign include . This etablishes tendency underestimate severity atypical depression .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<criteria>Main Mild moderate depression ( ICD10 F32.0 , F32.1 ) atypical feature accord DSMIV , last least 3 month Female male Caucasians age 18 70 year At least one HAMD28 scale item 2226 score &gt; 1</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>mild moderate depression atypical feature accord DSM-IV</keyword>
</DOC>